Open Access

Welcome and introduction - Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications.

Congress Session

About the speaker

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)
20 presentations
0 follower

5 more presentations in this session

Non-vitamin K antagonist oral anticoagulants in cardioversion: the ENSURE-AF study.

Speaker: Professor A. Goette (Paderborn, DE)

Thumbnail

Update from ENGAGE AF-TIMI 48: clinical implications.

Speaker: Doctor R. Giugliano (Boston, US)

Thumbnail

Management of atrial fibrillation: the new European Society of Cardiology 2016 Guidelines.

Speaker: Professor H. Heidbuchel (Edegem, BE)

Thumbnail

Panel discussion - Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications.

Speaker: Doctor J. Weitz (Hamilton, CA) Professor G. Lip (Liverpool, GB) Doctor R. Giugliano (Boston, US) Professor A. Goette (Paderborn, DE) Professor H. Heidbuchel (Edegem, BE)

Thumbnail

Summary and key messages - Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications.

Speaker: Professor G. Lip (Liverpool, GB)

Thumbnail

Access the full session

Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications

Speakers: Doctor J. Weitz, Professor A. Goette, Doctor R. Giugliano, Professor H. Heidbuchel, Doctor J. Weitz...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk